Nebius Stock Jumps 7.8% on $2.6B Bloom Energy Power Deal for AI Data Centers.
Mondeum Capital (UK) Limited
Nebius Group shares rose 7.8% in premarket trading after the AI cloud provider announced a $2.6 billion deal with Bloom Energy to supply fuel-cell power for its data centers. This move tackles a major challenge in building AI infrastructure. The deal also highlights the growing power crisis for neocloud operators and explains why Bloom Energy continues to secure big contracts.
This year, Bloom Energy’s fuel-cell systems will give Nebius 328 megawatts of installed capacity, delivered in three phases, each lasting 10 years. These systems generate electricity on-site, so they do not rely on the main electrical grid. This setup helps data center operators avoid two major problems: reliance on grid infrastructure and long wait times for new grid connections.
Nebius’s chief product and infrastructure officer said that power is a major challenge for building AI infrastructure. He pointed to Bloom’s ability to deliver clean power quickly as the main reason for the deal. For neocloud operators like Nebius, who need to bring computing power online fast, avoiding grid delays is crucial for their business.
Bloom Energy has benefited the most from this trend. Its stock is up more than 1,400% over the past year, including a 1.6% gain in premarket trading on Thursday after an 8% jump on Wednesday when the deal was announced. Since 2024, Bloom has signed new or expanded deals with CoreWeave, Oracle, and American Electric Power. After years of losses, analysts expect Bloom Energy to earn $475 million in 2026, over $1.2 billion in 2027, and $2.1 billion in 2028.
Nebius shares have climbed 407% in the past year as investors bet that the neocloud model can capture large-scale AI infrastructure spending.
Featured CoursesRecent news
IMAX Stock Jumps 15% on Sale Reports: Who’s Buying?
IMAX is considering a sale, sparking speculation about buyers. Shares rose 15% Friday after the Wall Street Journal reported IMAX approached entertainment companies. The process is early and may not end in a deal. Here are the analysts’ top buyer picks and what each could gain with IMAX. Netflix is attracting the most attention as […]
Merck Shares Jump 4.9% on Cancer Trial Win as Keytruda Patent Cliff Looms
Merck wants to show it is not just a one-drug company, and Friday’s clinical trial results gave it a boost. Shares rose 4.9% in premarket trading after a partner drug worked well in advanced lung cancer when used with Merck’s main cancer treatment. At the same time, European regulators moved closer to approving another Keytruda […]
Micron Stock Slips 1% After a Volatile Week for Memory Chip Stocks
Micron shares slipped 1% in early Friday trading after a week of ups and downs. The stock climbed from below $660 to a 4.1% gain on Thursday, but then fell back by Friday morning. This week, the memory chip sector was influenced by remarks from a competitor’s CEO, a narrowly avoided strike at Samsung, and […]
Trade with fewer limits
Day trade with fewer limits at fast speed. Buy stocks and ETFs at low fees.